|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Oxa 24,a novel class D beta lactamase with carbapenemase activity in an Axinetobacter baumannii clinical strain显示文摘 | OLIBER A MARTINEZ BELTRAN J | 2006 | Antimicrob Agents Chenother2006，44，6： | 1 |
| 2 | OXA- 24, a novel class D beta- lac-tamase with carbapenemase activity in an Acinetobacter baumannil clinical strain 显示文摘 | Bou G Oliber A Martinez- Behran J | 2000 | Antimicrob Agents Chemother2000，44，6： | 1 |
| 3 | New evidence against hydroxyl radicals as reactive intermediates in the thermal and photochemically enhanced Fenton reaction 显示文摘 | Bossmann S H Oliber E Gob S | 1998 | Physical Chemistry A1998，102，28： | 1 |
| 4 | New evidence against hydroxyl radicals as reactive intermediates in the thermal and photochemically enhanced Fenton reaction 显示文摘 | Bossmann S H Oliber E | 1998 | Phys Chem A1998，102，28： | 1 |
| 5 | OXA - 24, a novel class D beta - lacta- mase with carbapenemase activity in an Acinetobacter baumannii clinicalstrain 显示文摘 | Bou G Oliber A Martinez - Beltran J | 2000 | Antimicrob Agents Chemother2000，44，6： | 1 |
| 6 | OXA-24,a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannil clinical strain显示文摘 | Bou G Oliber A Martinez-Behran J | 2000 | Antimicrob Agents Chemother2000，44，6： | 1 |
| 7 | OXA-24,a novel class D beta lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain显示文摘 | Bou G Oliber A Martinez-Beltran J | 2000 | Antimicrob Agents Chemother2000，44，6： | 1 |
| 8 | OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobaeter baumannii clinical strain 显示文摘 | Bou G Oliber A Martinez-Beltran J | 2000 | Antimicrob Agents Chemother2000，44，6： | 1 |
| 9 | New evidence against hydroxyl radicals as reactive intermediates in the thermal and photochemically enhancend fenton rection显示文摘 | Bossmann S H Oliber E | 1998 | Phys Chem A1998，102，28： | 1 |
| 10 | The effect of R&D investment on firm values: an examination of US manufacturing and service industries 显示文摘 | EHIE I C OLIBE K | 2010 | Production Economics2010，，128： | 1 |
| 11 | New evidence against hydroxyl radicals as reactive intermediates in the thermal and photochemically enhanced Fenton reaction显示文摘 | Bossmann S H Oliber E | 1998 | Phys Chem A1998，102，28： | 1 |
| 12 | Variation in allyl isothiocyanate production within Brassica species and correlation with fungicidal activity显示文摘 | OLIBER C VAUGHN S F MIZUBUTI E S G | 1999 | Journal of Chemical Ecology1999，25，12： | 1 |
| 13 | Why Has China Survived the Asian Crisis So Well? What Risks Remain? 显示文摘 | Babson Oliber | 1999 | International Finance Discussion Paper Federal Reserve Board1999，，33： | 1 |
| 14 | OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain显示文摘 | G Oliber A Martinez-Beltran J | 2000 | Antimicrob Agents Chemother2000，44，6： | 1 |
| 15 | Oxa-24, a novel class D beta-lactamase activity in an axinetobacter banmannii clinical strain显示文摘 | BOU G OLIBER A MARTINEZ-B J | 2000 | Antimicrob Agents Chenother2000，44，6： | 1 |
| 16 | OXA-24, a novel class D beta-laetamase with carbapenemase activity in an Acinetobacter baumannii clinical strain显示文摘 | Bou G Oliber A Martinez-Beltran J | 2000 | Antimicrob Agents Chemother2000，44，6： | 1 |
| 17 | The effect of R&D investment on firm value:An examination of US manufacturing and service industries显示文摘 | IKE C EHIE KINGSLEY OLIBE | 2010 | Production Economics2010，，128： | 1 |
| 18 | The Effect of R&D Investment on Firm Value:An Examination of US Manufacturing and Service Industries显示文摘 | Ehie I C Olibe K | 2010 | International Journal of Production Economics2010，128，1： | 1 |
| 19 | New evidence against hydroxyl radicals as reactive intermediates in the thermal andphotochemically enhanced Fenton reaction显示文摘 | Bossmann S H Oliber E | 1998 | Phys Chem A1998，102，28： | 1 |
| 20 | OXA-24, a novel class D beta lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain显示文摘 | Bou G Oliber A Martinez-Beltran J | 2000 | Antimicmb Agen Chemother2000，44，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员